Not available
Quote | ProPhase Labs Inc. (NASDAQ:PRPH)
Last: | $6.3054 |
---|---|
Change Percent: | 0.73% |
Open: | $6.46 |
Close: | $6.26 |
High: | $6.46 |
Low: | $6.2273 |
Volume: | 6,458 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | ProPhase Labs Inc. (NASDAQ:PRPH)
2024-03-15 17:45:21 ET ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Conference Call March 15, 2024, 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive Officer Presentation Noella Alexan...
2024-03-15 08:01:58 ET More on ProPhase Labs ProPhase Labs eyes higher revenue for lozenge-making unit with improved pricing Seeking Alpha’s Quant Rating on ProPhase Labs Historical earnings data for ProPhase Labs Financial information for ProPhase Lab...
Message Board Posts | ProPhase Labs Inc. (NASDAQ:PRPH)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PRPH News Article - ProPhase Labs Announces New $6 Million Stock Repurchase Program | whytestocks | investorshangout | 03/15/2023 1:55:46 PM |
whytestocks: $PRPH News Article - ProPhase Labs Announces Data Presentation for its BE-Smart Esophag | whytestocks | investorshangout | 03/13/2023 3:05:51 PM |
whytestocks: $PRPH News Article - ProPhase Labs' Nebula Genomics Subsidiary Introduces Lowest Ever N | whytestocks | investorshangout | 03/07/2023 6:55:47 PM |
whytestocks: $PRPH News Article - ProPhase Labs to Present at The ThinkEquity Conference | whytestocks | investorshangout | 10/18/2022 5:20:57 PM |
whytestocks: $PRPH News Article - ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global | whytestocks | investorshangout | 09/06/2022 3:40:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion – set for rapid revenue and profit growth Completes full transition and right sized opera...
Tredegar Corporation (TG) is expected to report for quarter end 2023-12-31 Pharma-Bio Serv Inc (PBSV) is expected to report $0.02 for Q1 2024 Telos Corporation (TLS) is expected to report $-0.18 for Q4 2023 Coretec Group Inc (CRTG) is expected to report for quarter end 2023-12-31 ...
GARDEN CITY, NY, March 08, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting full year 2023 financial results on a virtual conference call hosted by Renmark Financial on March 15, 2024 at 11:00 am EDT. ProPhase Labs Inc. welcomes stakeholde...